CLOs on the Move

Walgreens Boots Alliance

www.walgreensbootsalliance.com

 
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led, health and wellbeing enterprise. The company`s heritage of trusted health care services through community pharmacy care and pharmaceutical wholesaling dates back more than 100 years. Walgreens Boots Alliance is the largest retail pharmacy, health and daily living destination across the U.S. and Europe. Walgreens Boots Alliance and the companies in which it has equity method investments together have a presence in more than 25* countries and employ more than 385,000* people. The company is a global leader in pharmacy-led, health and wellbeing retail and, together with the companies in which ...
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Danielle Gray
Executive Vice President and Global Chief Legal Officer Profile
Danielle Gray
Executive Vice President and Global Chief Legal Officer Profile
Matthew D`Ambrosio
Senior Vice President, Global Chief Compliance and Ethics Officer, and Interim Global Chief Legal Officer Profile
Matthew D`Ambrosio
Senior Vice President, Global Chief Compliance and Ethics Officer and Interim Chief Legal Officer Profile
Matthew D'Ambrosio
Senior Vice President, Global Chief Compliance and Ethics Officer Profile

Similar Companies

Zynex Medical

Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring.

The Ritedose Corporation,

  MANUFACTURING Philosophy The TRC team understands that the actions required to be a successful pharmaceutical manufacturer are more than just completing repetitive and highly detailed tasks accurately; it is the understanding that we...

Karyopharm

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm`s SINE compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm`s lead compound, XPOVIO™ (selinexor), received accelerated approval from the FDA in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development.

Honor Community Health

Honor Community Health (OIHN) is an HRSA-qualified community health center providing primary, behavioral health and dental care throughout Oakland County, Michigan.

Norwich Pharmaceuticals

Norwich Pharmaceuticals, Inc. is a Norwich, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.